Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/22/2022* -- Results Q4 2022 -- 1.39 --
11/22/2022* 13:30 EST Earnings Call Q4 2022 -- -- --
08/16/2022 -- Results Q3 2022 1.34 1.21 10.96%
08/16/2022 16:30 EST Earnings Call Q3 2022 -- -- --
05/24/2022 -- Results Q2 2022 1.13 1.12 1.33%
05/24/2022 16:30 EST Earnings Call Q2 2022 -- -- --
02/22/2022 -- Results Q1 2022 1.21 1.18 2.74%
02/22/2022 16:30 EST Earnings Call Q1 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/22/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/16/2022
Beat/Miss Upgrade
Return Since -7.00%
Last FQE 07/31/2022
Next FQE 10/31/2022

Profile

Edit
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
URL https://www.agilent.com
Investor Relations URL https://www.investor.agilent.com
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Large Cap/Blend
Next Earnings Release Nov. 22, 2022 (est.)
Last Earnings Release Aug. 16, 2022
Next Ex-Dividend Date Oct. 03, 2022
Last Ex-Dividend Date Jul. 01, 2022

Dividends

Dividend Per Share (TTM) 0.824
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.4897
Yield to Sector 0.3767
Yield to Industry 1.804
Last Dividend Amt. 0.21
Dividend Frequency Quarterly
Last Ex-Dividend Date Jul. 01, 2022
Yield (TTM) 0.67%
Forward Yield 0.68%
Payout Ratio 18.60%
Cash Payout Ratio 24.17%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
3.46%
10.15%
48.32%
1.67%
27.53%
39.77%
35.51%
-22.29%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-21.61%
-1.30%
15.75%
27.41%
12.61%
52.67%
45.39%
63.39%
-43.60%
-60.98%
68.75%
3.70%
-3.57%
11.11%
-43.31%
393.9%
-88.41%
--
--
--
--
28.09%
434.1%
143.1%
-51.32%
23.22%
-2.12%
40.85%
7.80%
24.01%
48.19%
40.37%
-39.09%
As of September 23, 2022.

Profile

Edit
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
URL https://www.agilent.com
Investor Relations URL https://www.investor.agilent.com
HQ State/Province California
Sector Healthcare
Industry Diagnostics & Research
Equity Style Large Cap/Blend
Next Earnings Release Nov. 22, 2022 (est.)
Last Earnings Release Aug. 16, 2022
Next Ex-Dividend Date Oct. 03, 2022
Last Ex-Dividend Date Jul. 01, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
FIW 48.23M USD 4.08%
PFPWX 128.25M USD 2.81%
PARMX 158.38M USD 2.34%
RRMGX 558.22M USD 2.03%
THISX 258.47M USD 1.67%
GFDDX 150.24M USD 1.58%
OTCGX 217.74M USD 1.55%
BMEZ 25.98M USD 1.22%
SUSA 34.86M USD 1.11%
IWP 117.05M USD 1.04%
IMCG 11.63M USD 1.03%
IWR 104.90M USD 0.41%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter A Tweets